Highlights of 2024: unleashing the power of NK cells-cancer's worst nightmare

Capucine Bourel1,2, Fernando Souza-Fonseca-Guimaraes3, Sylvie Lesage1,2

  • 1Immunologie-oncologie, Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.

PubMed

Insights

Strategies to enhance natural killer (NK) cell cancer therapies are discussed, including bacterial cytokine expression, CAR-NK cell optimization, CRISPR-Cas9 gene targeting, and tetraspecific engagers for improved anti-tumor responses.

Area of Science:

  • Immunology
  • Cancer Therapy
  • Cellular Engineering

Background:

  • Natural killer (NK) cells are crucial for innate immunity against cancer.
  • Enhancing NK cell activity is a promising strategy for novel cancer treatments.
  • Current NK cell therapies face challenges in efficacy and manufacturing.

Purpose of the Study:

  • To review recent advancements in NK cell-based cancer therapies.
  • To highlight innovative strategies for boosting NK cell anti-tumor functions.
  • To discuss the potential of these strategies in clinical applications.

Main Methods:

  • Engineering bacterial membranes for cytokine delivery to tumors.
  • Optimizing chimeric antigen receptor (CAR)-NK cell manufacturing processes.
  • Utilizing CRISPR-Cas9 gene editing to modulate NK cell activity.
  • Developing tetraspecific engagers for enhanced NK cell cytotoxicity.

Main Results:

  • Bacterial cytokine expression can significantly enhance NK cell activation within tumors.
  • Optimized CAR-NK cell manufacturing improves therapeutic efficacy.
  • CRISPR-Cas9 facilitates the identification and targeting of inhibitory NK cell genes.
  • Tetraspecific engagers and cytokine memory-like NK cells strengthen anti-tumor immune responses.

Conclusions:

  • Significant progress in 2024 offers new avenues for NK cell-based cancer treatments.
  • These strategies collectively promise to improve the effectiveness of cancer immunotherapies.
  • Further research and development are expected to translate these findings into clinical benefits.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
3.4K